| Product Code: ETC6174104 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Antiretroviral Therapy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Antiretroviral Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Antiretroviral Therapy Market - Industry Life Cycle |
3.4 Australia Antiretroviral Therapy Market - Porter's Five Forces |
3.5 Australia Antiretroviral Therapy Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Australia Antiretroviral Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Antiretroviral Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Australia Antiretroviral Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Antiretroviral Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Australia |
4.2.2 Growing awareness and initiatives for HIV prevention and treatment |
4.2.3 Technological advancements in antiretroviral therapy |
4.3 Market Restraints |
4.3.1 High cost associated with antiretroviral therapy |
4.3.2 Stigma and discrimination against people living with HIV/AIDS |
4.3.3 Regulatory challenges and approval process for new antiretroviral drugs |
5 Australia Antiretroviral Therapy Market Trends |
6 Australia Antiretroviral Therapy Market, By Types |
6.1 Australia Antiretroviral Therapy Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Antiretroviral Therapy Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Australia Antiretroviral Therapy Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.4 Australia Antiretroviral Therapy Market Revenues & Volume, By HIV Protease Inhibitors, 2021- 2031F |
6.1.5 Australia Antiretroviral Therapy Market Revenues & Volume, By Non-nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.6 Australia Antiretroviral Therapy Market Revenues & Volume, By Nucleotide Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.7 Australia Antiretroviral Therapy Market Revenues & Volume, By HIV Fusion Inhibitors, 2021- 2031F |
6.1.8 Australia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Antiretroviral Therapy Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Antiretroviral Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Antiretroviral Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Australia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Antiretroviral Therapy Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Antiretroviral Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Antiretroviral Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Australia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Antiretroviral Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Antiretroviral Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Antiretroviral Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Australia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Antiretroviral Therapy Market Import-Export Trade Statistics |
7.1 Australia Antiretroviral Therapy Market Export to Major Countries |
7.2 Australia Antiretroviral Therapy Market Imports from Major Countries |
8 Australia Antiretroviral Therapy Market Key Performance Indicators |
8.1 Number of patients on antiretroviral therapy |
8.2 Average treatment adherence rates |
8.3 Percentage of newly diagnosed HIV cases initiating antiretroviral therapy |
9 Australia Antiretroviral Therapy Market - Opportunity Assessment |
9.1 Australia Antiretroviral Therapy Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Australia Antiretroviral Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Antiretroviral Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Australia Antiretroviral Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Antiretroviral Therapy Market - Competitive Landscape |
10.1 Australia Antiretroviral Therapy Market Revenue Share, By Companies, 2024 |
10.2 Australia Antiretroviral Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here